Comments on: Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept) https://thegbm.com/alvotech-and-teva-announce-filing-acceptance-of-u-s-biologics-license-application-for-avt06-a-proposed-biosimilar-to-eylea-aflibercept/ Business news, opinion, reviews, interviews Tue, 18 Feb 2025 11:00:00 +0000 hourly 1 https://wordpress.org/?v=6.7.2